top of page

Our team of executives, pharmaceutical developers, and scientists envision a world where every patient has options and access to the care they need at every stage of disease. We are focused on transitioning strong pre-clinical scientific evidence into actionable treatments to expand options for patients with rare and aggressive cancers. We are a versatile team that puts the patient first.

Clinical Advisory Board

Sean-Dulloo-portrait-LIGHTER-scaled-e1716580606868-768x768-1.0.png

Sean Dulloo,
MRCP (MD)

Board Chair

PIP NEW HEADSHOT.jpg

Phillippa Graham,
MBChB (MD)

Director

Dean-Fennell-5.jpg

Dean Fennell,
MRCP, FRCP (MD/PhD)

Director

JSpicer3.0-300x300.png

James Spicer,
MRCP, FRCP (MD/PhD)

Director

Leadership Team

Jarr_Duncan_color.jpeg

Jarrett Duncan

Chief Executive Officer

George-Naumov-1.0.png

George Naumov, PhD

Chief Operating Officer

Brian-Cunniff.jpeg

Brian Cunniff, PhD, CSO

Chief Science Officer

Nichole-Hicks-BW-768x768-1.0.png

Nichole Pfeiffer Hicks

Patient Advocacy Liaison & Strategic Partnerships

christine-linnehan-sununu-headshot.jpg

Christine Linnehan-Sununu

Communications & Branding

rso footer.jpg
bottom of page